Novartis Leukemia Drug Buyers Blast 'Sham' Patent Suit
Third-party purchasers of a Novartis leukemia drug told a Massachusetts federal judge Monday that the company lied to patent examiners about how easy it was to come up with the $2...To view the full article, register now.
Already a subscriber? Click here to view full article